Non-Small Cell Lung Cancer Clinical Trials

A listing of Non-Small Cell Lung Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Arizona

UPDATED

Goodyear Arizona

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

UPDATED

Phoenix Arizona 85054

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Tucson Arizona 85719

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

California

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92307

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

UPDATED

La Jolla California 92093-0698

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

View More ▼

UPDATED

La Jolla California 92037-0845

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

UPDATED

Los Angeles California 90032

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Los Angeles California

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

UPDATED

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Orange California 92868

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Orange California 92868

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Panorama City California 91402

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Redwood City California 94063

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Sacramento California 95825

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

San Diego California 92103

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

UPDATED

San Francisco California 94143

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Santa Monica California 90403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Santa Rosa California 95403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Denver Colorado

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

Connecticut

UPDATED

Fairfield Connecticut 06824

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

New Haven Connecticut 06519

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

New Haven Connecticut 06510

A Phase 1 clinical study for patients with Non-Small Cell Lung Cancer (NSCLC)

UPDATED

New Haven Connecticut

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

UPDATED

Norwich Connecticut 06360

Patients are needed to participate in a clinical research study to evaluate Non-Small Cell Lung Cancer

District of Columbia

UPDATED

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Florida

UPDATED

Gainesville Florida 32611

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Miami Florida 33176

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Sarasota Florida 34232

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Sarasota Florida

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

UPDATED

Tampa Florida 33612

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

View More ▼

UPDATED

Tampa Florida 33612

Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer

UPDATED

Tampa Florida

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

UPDATED

Weston Florida 33331

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Georgia

UPDATED

Athens Georgia 30607

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Atlanta Georgia 30309

Patients are needed to participate in a clinical research study of NovoTTF-100M device and Best Standard of Care to evaluate Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

UPDATED

Newnan Georgia 30265

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Hawaii

UPDATED

Honolulu Hawaii 96813

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Illinois

UPDATED

Chicago Illinois 60611

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Chicago Illinois 60637

Patients are needed to participate in a clinical research study evaluating LOXO-292 for the treatment of Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer or Solid Tumor